Inhaled NO as a therapeutic agent
Authors:
- K BlochKBK Bloch
- F IchinoseFIF Ichinose
- J RobertsjrJRJ Robertsjr
- W ZapolWZW Zapol
- 15 July 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 75 (2) , 339-348
Abstract
In 1991, Frostell and colleagues reported that breathing low concentrations of nitric oxide (NO) decreased pulmonary artery pressure (PAP) in awake lambs with experimental pulmonary hypertension (PH) [Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991;83:2038-47]. Subsequently, efforts of multiple research groups studying animals and patients led to approval of inhaled NO by the US Food and Drug Administration in 1999 and the European Medicine Evaluation Agency and European Commission in 2001. Inhaled NO is currently indicated for the treatment of term and near-term neonates with hypoxemia and PH. Since regulatory approval, several studies have suggested that NO inhalation can prevent chronic lung disease in premature infants. In addition, unanticipated systemic effects of inhaled NO may lead to treatments for a variety of disorders including ischemia-reperfusion injury. This review summarizes the pharmacology and physiological effects of breathing NO. The application of inhaled NO to hypoxemic neonates with PH is discussed including recent studies exploring the use of inhaled NO to prevent bronchopulmonary dysplasia in premature infants. This review also highlights the application of inhaled NO to treat adults with cardiopulmonary disease, strategies to augment the efficacy of inhaled NO, and potential applications of the systemic effects of the gas.Keywords
This publication has 85 references indexed in Scilit:
- Use of inhaled nitric oxide in the preterm infantCurrent Opinion in Pediatrics, 2007
- Inhaled nitric oxide therapy in premature newbornsCurrent Opinion in Pediatrics, 2006
- Inhaled Nitric Oxide for Premature Infants with Severe Respiratory FailureNew England Journal of Medicine, 2005
- Neurodevelopmental Outcomes of Premature Infants Treated with Inhaled Nitric OxideNew England Journal of Medicine, 2005
- The safety and efficacy of nitric oxide therapy in premature infantsThe Journal of Pediatrics, 2005
- Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shockJACC, 2004
- Inhaled Nitric Oxide as a Prophylactic Treatment Against Reperfusion Injury of the LungThe Thoracic and Cardiovascular Surgeon, 1999
- Effect of nitric oxide on the survival rate and incidence of lung injury in newborn lambs with persistent pulmonary hypertensionThe Journal of Pediatrics, 1993
- Treatment of persistent pulmonary hypertension in the newborn lamb by inhaled nitric oxideThe Journal of Pediatrics, 1993
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993